Ibrutinib
Products in Health Canada’s databases that list Ibrutinib as a medicinal or active ingredient, under this spelling. The same substance can be listed under another name (a salt, a common name), which has its own page.
- Drug products
- 6
- 6 authorized now
- Natural health products
- 0
- 0 active licences
- Notices of Compliance
- 23
- Products in all
- 6
Drug products
Authorized products first.
| Name | DIN | Status | Holder | Status since |
|---|---|---|---|---|
| IMBRUVICA (140 MG) | 02434407 | Marketed | Janssen Inc. | |
| IMBRUVICA (70 MG) | 02540215 | Marketed | Janssen Inc. | |
| IMBRUVICA (140 MG) | 02486733 | Approved | Janssen Inc. | |
| IMBRUVICA (280 MG) | 02486741 | Approved | Janssen Inc. | |
| IMBRUVICA (420 MG) | 02486768 | Approved | Janssen Inc. | |
| IMBRUVICA (560 MG) | 02486776 | Approved | Janssen Inc. |
Notices of Compliance
Approvals of drug submissions that list it, newest first.
- IMBRUVICADecember 2, 2025 · NOC 36469
- IMBRUVICAMarch 20, 2025 · NOC 35055
- IMBRUVICAAugust 4, 2023 · NOC 31369
- IMBRUVICAMarch 20, 2023 · NOC 30342
- IMBRUVICAJune 29, 2022 · NOC 28497
- IMBRUVICADecember 16, 2021 · NOC 27250
- IMBRUVICAJune 2, 2021 · NOC 25972
- IMBRUVICAMarch 5, 2021 · NOC 25384
- IMBRUVICADecember 15, 2020 · NOC 24798
- IMBRUVICASeptember 28, 2020 · NOC 24311
- IMBRUVICANovember 6, 2019 · NOC 22862
- IMBRUVICAMay 6, 2019 · NOC 22128
- IMBRUVICAMarch 20, 2019 · NOC 21985
- IMBRUVICAFebruary 11, 2019 · NOC 21854
- IMBRUVICAJuly 24, 2018 · NOC 21131
- IMBRUVICAOctober 25, 2017 · NOC 19964
- IMBRUVICASeptember 12, 2017 · NOC 19807
- IMBRUVICAFebruary 1, 2017 · NOC 18929
- IMBRUVICAJuly 19, 2016 · NOC 18397
- IMBRUVICAMarch 31, 2016 · NOC 17958
- IMBRUVICAMarch 18, 2016 · NOC 17890
- IMBRUVICAJuly 28, 2015 · NOC 17141
- IMBRUVICANovember 17, 2014 · NOC 16303